Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.05M Sell
29,517
-430
-1% -$33.1K 0.23% 75
2025
Q4
$2.28M Buy
29,947
+812
+3% +$65.2K 0.24% 71
2025
Q3
$2.51M Sell
29,135
-3,680
-11% -$278K 0.27% 66
2025
Q2
$2.24M Sell
32,815
-853
-3% -$52.8K 0.25% 70
2025
Q1
$2M Buy
33,668
+13,026
+63% +$826K 0.23% 76
2024
Q4
$1.25M Sell
20,642
-11,265
-35% -$690K 0.14% 87
2024
Q3
$2.3M Sell
31,907
-2,125
-6% -$148K 0.25% 73
2024
Q2
$2.4M Sell
34,032
-1,700
-5% -$131K 0.28% 68
2024
Q1
$2.85M Sell
35,732
-1,196
-3% -$96.4K 0.33% 66
2023
Q4
$3.31M Sell
36,928
-3,241
-8% -$279K 0.41% 59
2023
Q3
$3.96M Buy
40,169
+382
+1% +$39.5K 0.55% 53
2023
Q2
$4.06M Buy
39,787
+6,934
+21% +$686K 0.54% 56
2023
Q1
$3.69M Buy
32,853
+870
+3% +$96K 0.53% 55
2022
Q4
$2.98M Sell
31,983
-13,249
-29% -$1.26M 0.44% 62
2022
Q3
$3.54M Sell
45,232
-3,929
-8% -$377K 0.54% 57
2022
Q2
$4.38M Buy
49,161
+5,511
+13% +$562K 0.56% 57
2022
Q1
$5.22M Buy
43,650
+7,261
+20% +$966K 0.56% 58
2021
Q4
$6M Buy
36,389
+2,617
+8% +$437K 0.58% 56
2021
Q3
$5.03M Buy
+33,772
New +$5.26M 0.54% 56

Other funds holding APTV

Middleton & Co's APTV Position: Q1 2026 in Review

Middleton & Co reduced its Aptiv (APTV) stake by 1.4% in Q1 2026, selling an estimated $33.1K and leaving 29,517 shares worth $2.05M. The position accounts for 0.23% of the portfolio, ranked #75.

Middleton & Co first reported a position in APTV in Q3 2021 and has held it in 19 quarters since. The position peaked at $6M in Q4 2021. 706 funds tracked by Wall St. Rank hold APTV as of Q1 2026.

  • Middleton & Co held 29,517 shares of Aptiv worth $2.05M as of Q1 2026.
  • Middleton & Co sold 430 Aptiv shares in Q1 2026, an estimated $33.1K.
  • Aptiv made up 0.23% of Middleton & Co's portfolio in Q1 2026, its #75 holding.
  • Middleton & Co first reported a position in Aptiv in Q3 2021 and has held it in 19 quarters since.
  • Middleton & Co's Aptiv position peaked at $6M in Q4 2021.
  • 706 funds tracked by Wall St. Rank held Aptiv as of Q1 2026.

Based on Middleton & Co's 13F filing for Q1 2026, filed 8 May 2026.